China Aims to Introduce Routine Drug and Device Overseas Inspections

Published date14 January 2019
Law FirmRopes & Gray LLP
AuthorKatherine Wang
Subject MatterMedical Devices,China,Prescription Drugs,Inspections,Foreign Entities,Pharmaceutical Industry

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT